InMed Pharmaceuticals Announces $5.2 Million Private Placement and Preferred Investment Option Exercise Priced At-the-Market under Nasdaq Rules
Stock Information for InMed Pharmaceuticals Inc.
Loading
Please wait while we load your information from QuoteMedia.